D-dimer – Understanding the concept and value
June 30, 2020
Webinar presented by Guillaume Galpy.
About this webinar
Learn more and get answers to your questions on D-dimer - How important is D-dimer in the management of patients with Venous Thromboembolism? What an elevated D-dimer in a COVID-19 patient would mean?
Several research work and publications lately have highlighted the potential prognostic value of numerous biomarkers in COVID-19 patients leading to revised guidelines and recommendations. One such biomarker of high importance is D-dimer. Older age, elevated d-dimer levels (greater than 1 µg/L), and clinical probability assessment, on admission, have been included as risk factors for COVID-19 related mortality1.
About the speaker
Having worked on acute care testing for more than 24 years, Guillaume has been a global industry expert in the field of Immunoassay. He is the name behind the launch of the first Troponin I automated assay in 1995 and several other markers such as natriuretic peptides and D-dimer. After Graduating in Biology and Marketing from the University of Nice and Lyon in France, he joined Radiometer and is currently working as a Global Market Development Manager for Immunoassay at Radiometer Medical, Copenhagen.
Who should attend?
- Critical Care Specialists/Consultants
- Lab Professionals – Consultants/Managers/Technical Staff
- Clinical and Biomedical Biochemists
- Point of care Coordinators
This webinar will describe:
- What is D-dimer test and how can it be used in practice?
- What does an elevated D-dimer in COVID-19 patients mean?
- How to define a high-quality D-dimer assay
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28; 395(10229): 1054-1062.